title: Estimation of dioxin and furan elimination rates with a pharmacokinetic model.
abstract: Quantitative description of the pharmacokinetics of dioxins and furans in humans can be of great help for the assessment of health risks posed by these compounds. To that the elimination rates of sixteen 2,3,7,8-chlorinated dibenzodioxins and dibenzofurans are estimated from both a longitudinal and a cross-sectional data set using the model of Van der Molen et al. [Van der Molen G.W., Kooijman S.A.L.M., and Slob W. A generic toxicokinetic model for persistent lipophilic compounds in humans: an application to TCDD. Fundam Appl Toxicol 1996: 31: 83-94]. In this model the elimination rate is given by the (constant) specific elimination rate multiplied with the ratio between the lipid weight of the liver and total body lipid weight. Body composition, body weight and intake are assumed to depend on age. The elimination rate is, therefore, not constant. For 49-year-old males, the elimination rate estimates range between 0.03 per year for 1,2,3,6,7,8-hexaCDF to 1.0 per year for octaCDF. The elimination rates of the most toxic congeners, 2,3,7,8-tetraCDD, 1,2,3,7,8-pentaCDD, and 2,3,4,7,8-pentaCDF, were estimated at 0.09, 0.06, and 0.07, respectively, based on the cross-sectional data, and 0.11, 0.09, and 0.09 based on the longitudinal data. The elimination rates of dioxins decrease with age between 0.0011 per year for 1,2,3,6,7,8-hexaCDD and 0.0035 per year for 1,2,3,4,6,7,8-heptaCDD. For furans the average decrease is 0.0033 per year. The elimination rates were estimated both from a longitudinal and a cross-sectional data set, and agreed quite well with each other, after taking account of historical changes in average intake levels.
authors.affiliation: Faculty of Biology, Vrije Universiteit, Amsterdam, Netherlands.
authors.forename: G W
authors.initials: GW
authors.lastname: Van der Molen
authors.forename: B A
authors.initials: BA
authors.lastname: Kooijman
authors.forename: J
authors.initials: J
authors.lastname: Wittsiepe
authors.forename: P
authors.initials: P
authors.lastname: Schrey
authors.forename: D
authors.initials: D
authors.lastname: Flesch-Janys
authors.forename: W
authors.initials: W
authors.lastname: Slob
mesh_terms: D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000368:Aged; D001835:Body Weight; D002648:Child; D002675:Child, Preschool; D004147:Dioxins / Q000493:pharmacokinetics*; D004785:Environmental Pollutants / Q000493:pharmacokinetics*; D005260:Female; D005663:Furans / Q000493:pharmacokinetics*; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D008875:Middle Aged; D008962:Models, Theoretical; D011634:Public Health; D018570:Risk Assessment; D012737:Sex Factors
chemical_list: D004147:Dioxins; D004785:Environmental Pollutants; D005663:Furans; C039281:furan